OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees

BioReference initiates COVID-19 testing for all National Basketball Association players and referees, as well as team and league staff for its season restart in Orlando on July 30 ELMWOOD PARK, N.J., July 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), will provide COVID-19 testing oversight for the National Basketball Association’s (NBA) players […]

OPKO Health’s BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents

In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]

OPKO Health’s BioReference Laboratories and GeneDx Increase COVID-19 Response Through Expanded Testing Capacity

GeneDx’s Gaithersburg and BioReference’s Melbourne facilities offer COVID-19 testing ELMWOOD PARK, N.J., April 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced its subsidiary GeneDx will begin testing for COVID-19 to further expand public access to testing. In addition, BioReference will leverage its Melbourne, Florida facility to increase COVID-19 testing capacity, […]

OPKO Health’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)

In partnership with NY State Department of Health, BioReference will provide COVID-19 testing for the first public drive-through testing facility on the East Coast COVID-19 tests now available for use by healthcare providers throughout the US ELMWOOD PARK, N.J., March 13, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now […]